Working… Menu

Phase 1 Trial of Ebola Vaccine in Mali

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02267109
Recruitment Status : Completed
First Posted : October 17, 2014
Last Update Posted : September 26, 2019
Wellcome Trust
National Institute of Allergy and Infectious Diseases (NIAID)
Leidos Biomedical Research, Inc.
Information provided by (Responsible Party):
Milagritos Tapia, University of Maryland, Baltimore